Document Detail


Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival.
MedLine Citation:
PMID:  20595154     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The identification of tumour biomarkers that detect the presence of disease using noninvasive diagnostic procedures is a key part of cancer research. We determined in plasma the vesicle-related microRNA (miRNA) expression profile of nonsmall cell lung cancer (NSCLC) and evaluate whether plasma miRNAs can be both discriminating (between patients and healthy controls) and prognostic markers. 365 human miRNAs were analysed by Taqman® low-density arrays (Applied Biosystems, Foster City, CA, USA) in the plasma from 28 NSCLC patients and 20 controls. Five selected miRNAs (let-7f, miR-20b, miR-30e-3p, miR-223 and miR-301) were validated independently by real-time PCR in plasma from 78 NSCLC and 48 controls and correlated with pathologic parameters and survival. Levels of let-7f, miR-20b and miR-30e-3p were decreased in plasma vesicles of NSCLC patients. Moreover, levels of let-7f and miR-30e-3p distinguished between two groups of patients for stage of disease and therefore possibility of surgery. Plasma levels of miR-30e-3p and let-7f were associated with short disease-free survival and overall survival, respectively. NSCLC patients and healthy controls differ in vesicle-related miRNAs in plasma. Levels of let-7f and miR-30e-3p in NSCLC patients are associated with poor outcome. Thus, plasma vesicle-related miRNAs obtained by noninvasive methods could serve as circulating tumour biomarkers of discriminating and prognostic value.
Authors:
J Silva; V García; Á Zaballos; M Provencio; L Lombardía; L Almonacid; J M García; G Domínguez; C Peña; R Diaz; M Herrera; A Varela; F Bonilla
Related Documents :
6153944 - Transient increase in serum creatine kinase isoenzyme bb activity after prostatectomy i...
3156024 - Ciprofloxacin distribution in prostatic tissue and fluid following oral administration.
2734984 - Circulating testosterone, prostatic nuclear androgen receptor and time to progression i...
9228514 - Epididymal and sex accessory gland secretions in transfusion-dependent beta-thalassemic...
3146034 - Modulatory actions of luteinizing hormone-releasing hormone on electrical activity of p...
22150314 - Trends in sex hormone concentrations in us males: 1988-1991 to 1999-2004.
Publication Detail:
Type:  Journal Article     Date:  2010-07-01
Journal Detail:
Title:  The European respiratory journal     Volume:  37     ISSN:  1399-3003     ISO Abbreviation:  Eur. Respir. J.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-03-01     Completed Date:  2011-06-21     Revised Date:  2013-05-23    
Medline Journal Info:
Nlm Unique ID:  8803460     Medline TA:  Eur Respir J     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  617-23     Citation Subset:  IM    
Affiliation:
Dept of Medical Oncology, Puerta de Hierro Majadahonda University Hospital, C/Joaquín Rodrigo, 2; E-28222 Majadahonda, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carcinoma, Non-Small-Cell Lung / metabolism*,  mortality
Case-Control Studies
Disease-Free Survival
False Positive Reactions
Female
Gene Expression Profiling / methods
Gene Expression Regulation, Neoplastic
Genetic Markers
Humans
Lung Neoplasms / metabolism*,  mortality
Male
MicroRNAs / metabolism*
Prognosis
Tumor Markers, Biological
Chemical
Reg. No./Substance:
0/Genetic Markers; 0/MicroRNAs; 0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Procedure volume is one determinant of centre effect in mechanically ventilated patients.
Next Document:  Particle size matters: diagnostics and treatment of small airways involvement in asthma.